Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$132,641
-$634,116 QoQ
Shares Held
2,302
-83.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,206
of 2,506 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. BMY ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
90,150 | $17,094,243 | |
| 2 | SNY |
Sanofi
|
115,761 | $4,938,364 | |
| 3 | NVO |
Novo Nordisk A S
|
47,719 | $2,287,648 | |
| 4 | GSK |
GSK plc
|
15,941 | $835,627 | |
| 5 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,941 | $245,225 | |
| 7 | PFE |
Pfizer Inc
|
7,242 | $174,387 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
2,302 | $132,641 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,641 | 2,302 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $766,757 | 14,215 | Shares | Defined | 2026-02-17 | |
| 2024-06-30 | $94,812 | 2,283 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $8,055 | 157 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||